Table 1 Data collection.
From: HCG supplement did not accelerate tunica albuginea remodeling to facilitate penile growth
Control | Anti-LOX | HCG | VED | Anti-LOX + VED | HCG + VED | Anti-LOX + HCG + VED | p | |
|---|---|---|---|---|---|---|---|---|
Primary weight (g) | 132.17 ± 1.77 | 131.67 ± 1.25 | 132.50 ± 2.63 | 132.00 ± 1.83 | 136.67 ± 3.45 | 133.33 ± 2.36 | 134.50 ± 5.44 | 0.1292 |
Final weight (g) | 264.67 ± 12.41 | 269.17 ± 11.54 | 268.50 ± 6.65 | 258.50 ± 12.61 | 253.17 ± 7.73 | 249.33 ± 18.94 | 246.33 ± 9.66 | 0.0185 |
Testicular weight (g) | 16.05 ± 1.00 | 15.66 ± 0.60 | 11.83 ± 2.26 | 15.95 ± 1.39 | 16.35 ± 0.73 | 11.08 ± 2.24 | 9.93 ± 2.68 | < 0.0001 |
Penile length (mm) | 31.00 ± 1.32 | 35.58 ± 0.19 | 33.33 ± 1.21 | 34.75 ± 0.85 | 38.92 ± 0.89 | 34.17 ± 0.80 | 37.92 ± 0.84 | < 0.0001 |
Exposed penile length (mm) | 28.08 ± 0.53 | 30.50 ± 0.65 | 28.83 ± 0.69 | 30.75 ± 0.25 | 33.42 ± 0.89 | 31.17 ± 1.55 | 33.25 ± 0.80 | < 0.0001 |
ICP | 63.45 ± 14.70 | 71.89 ± 5.11 | 61.21 ± 8.31 | 79.61 ± 23.17 | 82.54 ± 18.61 | 68.06 ± 11.44 | 77.02 ± 12.33 | 0.1824 |
MAP | 114.21 ± 10.48 | 111.87 ± 12.18 | 121.70 ± 8.40 | 130.75 ± 12.44 | 125.31 ± 24.69 | 118.00 ± 11.26 | 114.06 ± 18.32 | 0.4036 |
ICP/MAP | 0.56 ± 0.12 | 0.65 ± 0.06 | 0.51 ± 0.08 | 0.60 ± 0.16 | 0.65 ± 0.06 | 0.58 ± 0.05 | 0.68 ± 0.04 | 0.0540 |
